ROSE KNIGHT: Open Payments
NPI 1699364307 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,614 in 175 payments from 20 companies in 2025. Trend: 2023 $2,715 · 2024 $3,311 · 2025 $3,614
Food & beverage: $3,399Education: $216
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $639 |
| Arcutis Biotherapeutics, Inc. | 26 | $503 |
| Regeneron Healthcare Solutions, Inc. | 15 | $439 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $289 |
| GENZYME CORPORATION | 10 | $217 |
| UCB, Inc. | 16 | $207 |
| Botanix SB Inc | 16 | $156 |
| Incyte Corporation | 9 | $147 |
| PFIZER INC. | 9 | $144 |
| MAYNE PHARMA COMMERCIAL LLC | 6 | $141 |
Products named: DUPIXENT, SKYRIZI, Zoryve, Bimzelx, SOFDRA, OPZELURA, CIBINQO, Neo-Synalar.
Industry payments across TX — which companies pay providers there.
